Cessatech is a Danish company active in the pharmaceutical industry. The company specializes in the research and development of analgesic nasal spray that is further used for the treatment of acute pain conditions among children. In addition to the main business, service and associated ancillary services are also offered. The business is run globally with the largest presence in the Nordic market.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Jes Trygved | 9,27 | 9,27 | 2022-07-11 |
| Buhl Krone Holding ApS | 8,82 | 8,82 | 2021-12-08 |
| Steen Winther Henneberg | 8,18 | 8,18 | 2022-07-11 |
| Bettina Nygaard Nielsen | 8,18 | 8,18 | 2022-07-11 |
| Avanza Bank AB | 6,73 | 6,73 | 2022-07-11 |
| Gainbridge Capital | 1,42 | 1,42 | 2022-08-31 |
| C-Aps | 1,12 | 1,12 | 2021-12-08 |
| Martin Olin | 1,09 | 1,09 | 2021-12-08 |
| Adam Steensberg | 0,74 | 0,74 | 2021-12-08 |
| Peter Birk | 0,17 | 0,17 | 2021-12-08 |
2022-11-18 Delårsrapport 2022-Q3
2023-03-03 Bokslutskommuniké 2022